(14S,17S)-N-(4-Methylbenzyl)-17-(2-(neopentylamino)-2-oxoethyl)-16,19-dioxo-6,7,8,9,10,11,14,15,16,17,18,19-dodecahydro-5H,13H-imidazo[2,1-i][1]oxa[4,7,10]triazacycloheptadecine-14-carboxamide (Compound)

Description: A compound in the knowledge graph

Analyze

CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View (14S,17S)-N-(4-Methylbenzyl)-17-(2-(neopentylamino)-2-oxoethyl)-16,19-dioxo-6,7,8,9,10,11,14,15,16,17,18,19-dodecahydro-5H,13H-imidazo[2,1-i][1]oxa[4,7,10]triazacycloheptadecine-14-carboxamide's neighborhood in the knowledge graph.

Submit

Knowledge Graph Assertions

	Source	Relation	Target	Evidence
	(14S,17S)-N-(4-Methylbenzyl)-17-(2-(neopentylamino)-2-oxoethyl)-16,19-dioxo-6,7,8,9,10,11,14,15,16,17,18,19-dodecahydro-5H,13H-imidazo[2,1-i][1]oxa[4,7,10]triazacycloheptadecine-14-carboxamide Compound (Entity type)	Bioactivity Knowledge Graph Relation (Entity type)	Proteasome subunit beta type-8 Protein (Entity type)	IC50
	(14S,17S)-N-(4-Methylbenzyl)-17-(2-(neopentylamino)-2-oxoethyl)-16,19-dioxo-6,7,8,9,10,11,14,15,16,17,18,19-dodecahydro-5H,13H-imidazo[2,1-i][1]oxa[4,7,10]triazacycloheptadecine-14-carboxamide Compound (Entity type)	Bioactivity Knowledge Graph Relation (Entity type)	Proteasome subunit beta type-5 Protein (Entity type)	IC50